Applied Photophysics, a leading provider of systems for biophysical characterization of biomolecules, today announced it has appointed Paul Walker as Non-Executive Director. The appointment completes the formation of the Company’s Board of Directors, which will provide a key strategic resource for directing future investment opportunities and building awareness of the Company and its product portfolio.

Paul held technical and management roles in the steel industry before establishing his own management consultancy. In 1993 he joined Malvern Instruments, a biotech instruments supplier, where he has been Managing Director for the past 20 years. Paul was awarded an MBE for services to Industry in 2012 and was Chairman of the Hereford and Worcestershire Chamber of Commerce for five years. He has been a Non-Executive Director of the Malvern Hills Science Park since 1999 and is a Fellow of the University of Worcester. Paul is a Chartered Engineer with B. Tech and M. Phil degrees in Materials Science from Bradford University. He joins a highly-experienced team on the Applied Photophysics Board, which also includes:

• Louise Madden, CEO and Executive Director at Applied Photophysics. With over a decade of experience within the analytical instruments field, Louise joined Applied Photophysics in March 2014 as commercial director, before being promoted to chief operating officer in 2015. With a BA in Law and Accountancy from the University of Manchester, Louise was previously Finance Director at Farfield Group Limited and Global Service Manager at Biolin Scientific AB. Before this, she spent 11 years at KPMG, where her clients ranged from owner-managed businesses to multi-national PLCs. Louise has also, during this time, gained extensive experience of mergers and acquisitions.

• David Berglund, Chairman. David has over 15 years’ experience of senior management roles spanning the financial services, high-tech, retail and life science industries, during which time he has developed the ability to identify and commercialize business opportunities for hardware, software and service offerings. In addition to a portfolio of minority investments, he works with one or two majority investments, actively driving the development of the companies. David has a MEng in Electronic Engineering from the University of Edinburgh.

• Dr. David Gregson, Vice Chairman. As a former Managing Director of Applied Photophysics, David guided the company through a program of continuous development to become a major supplier of circular dichroism technology, while maintaining its market-leading position in stopped-flow analysis. Prior to joining Applied Photophysics he gained a substantial proportion of his experience as technical director of the analytical instrument company VG Elemental (now part of Thermo Fisher Scientific). David has a Ph.D. in Chemistry from the University of Bristol.

• Dr. Gerry Ronan, Non-Executive Director. Gerry worked in corporate and SMEs for 20 years before joining Swansea University as Head of Commercial Services. He is now Managing Director of Swansea Innovations and head of IP commercialization for the university where he has championed a progressive approach to technology transfer, creating a vibrant pipeline of commercial opportunities. Gerry has considerable experience in the private sector, having worked in the fields of medical devices and drug discovery. He took a university start-up through to an investable proposition, trading profitably across 24 countries, before selling the company in 2011. Gerry is a Chartered Engineer and a Fellow of the Institute of Physics with a Ph.D. in Physics.

• Dr. Maris Hartmanis, Non-Executive Director. Maris has more than 30 years of CEO and senior executive R&D management experience from roles in the international life science markets, including pharmaceuticals, medtech, biotech, life science supply, diagnostics and healthcare. As a Board member of several companies he has extensive experience of private and listed companies and academia. He has also served on global executive management teams and science advisory boards. In CEO roles he has worked with large companies in business integration, turnaround management, divestment of subsidiaries, R&D portfolio management, strategic processes, market introductions, territorial expansion and interactions with global markets, investors and shareholders. Maris has a Ph.D. in Biochemistry from the KTH Royal Institute of Technology, Stockholm, where he also is an Associate Professor.

Commenting on the appointment, Louise Madden, CEO and Executive Director at Applied Photophysics, said: “The appointment of Paul to our Board of Directors underlines our strategic focus on strengthening and expanding our position in the biophysical characterization market. With their many years of experience and proven success in running biotech tools companies and generating investor interest, we will draw on the Board’s extensive network to raise awareness of our new generation, state-of-the-art Chirascan systems and identify synergistic opportunities.”

For more information about Applied Photophysics, visit